← MEDICAL PROPERTIES TRUST INC MPT
Market Price
$4.20
Market Cap
$2.52B
P/E Ratio
N/A
Revenue (FY 2025)
↓-2.4% YoY
$972.02M
3-Yr CAGR: -14.3%
Net Income
↑88.5% YoY
-$277.05M
Net Margin: -28.5%
Free Cash Flow
N/A
FCF Yield: N/A
EPS (Diluted)
↑88.6% YoY
$-0.46
Basic: $-0.46
Return on Equity
Efficiency
-6.0%
ROA: -1.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MPT)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $541.1M | — | $381.5M | $225.0M | — | $0.86 | — | $264.7M | — | — |
| FY 2017 | $704.7M | +30.2% | $527.8M | $289.8M | +28.8% | $0.82 | -4.7% | $363.1M | — | — |
| FY 2018 | $784.5M | +11.3% | $561.2M | $1,016.7M | +250.8% | $2.76 | +236.6% | $449.1M | — | — |
| FY 2019 | $854.2M | +8.9% | $616.4M | $374.7M | -63.1% | $0.87 | -68.5% | $494.1M | — | — |
| FY 2020 | $1,249.2M | +46.2% | $920.5M | $431.4M | +15.2% | $0.81 | -6.9% | $617.6M | — | — |
| FY 2021 | $1,544.7M | +23.6% | $1,177.3M | $656.0M | +52.1% | — | — | $811.7M | — | — |
| FY 2022 | $1,542.9M | -0.1% | $1,183.8M | $902.6M | +37.6% | $1.50 | — | $739.0M | — | — |
| FY 2023 | $871.8M | -43.5% | $460.6M | $-556.5M | -161.7% | $-0.93 | -162.0% | $505.8M | — | — |
| FY 2024 | $995.5M | +14.2% | $577.7M | $-2,410.3M | -333.1% | $-4.02 | -332.3% | $245.5M | — | — |
| FY 2025 | $972.0M | -2.4% | $461.7M | $-277.0M | +88.5% | $-0.46 | +88.6% | $230.8M | — | — |
Valuation
Market Price
$4.20
Market Cap
$2.52B
Enterprise Value
$11.67B
P/E Ratio
N/A
P/B Ratio
0.54
FCF Yield
N/A
Dividend Yield
7.87%
Shares Outstanding
Profitability & Margins
Gross Margin
47.49%
Operating Margin
-17.75%
Net Margin
-28.50%
Return on Equity (ROE)
-6.01%
Return on Assets (ROA)
-1.85%
Asset Turnover
0.06x
Revenue 3-Yr CAGR
-14.27%
Financial Health & Liquidity
Current Ratio
N/A
Cash Ratio
N/A
Debt / Equity
2.105
Debt / Assets
0.646
Cash & Equivalents
$540.86M
Total Debt
$9.70B
Book Value / Share
$7.70
Cash Flow Efficiency
Operating Cash Flow
$230.77M
Capital Expenditures (CapEx)
N/A
Free Cash Flow
N/A
OCF / Revenue
23.74%
FCF / Revenue
N/A
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-0.46
EPS (Basic)
$-0.46
Dividends / Share
$0.33
Book Value / Share
$7.70
EPS YoY Growth
88.56%
Balance Sheet (FY 2025)
Total Assets
$15.00B
Total Liabilities
$150.80M
Stockholders' Equity
$4.61B
Current Assets
N/A
Current Liabilities
N/A